Deals
Xiwang Agrees to Acquire Canada’s Iovate Health for $730 Million
- Deal for supplement maker expected to close this year
- Iovate will keep headquarters and employees in place
This article is for subscribers only.
Xiwang Foodstuffs Company Ltd. has agreed to buy Canadian nutrition supplement maker Iovate Health Sciences International Inc., according to statements from both companies.
The deal values Iovate at $730 million, Xiwang said in a filing with the Shenzhen Stock Exchange Monday. Xiwang outbid a number of other Chinese buyout firms that had made offers for the business, people familiar with the matter said earlier.